Taylor Ian
President, R&D at ARVN
- Sold, on record
- $7.7M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Feb 24, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ARVNARVINAS, INC.President, R&D
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ARVNPlan not statedApr 5, 2021 2021
Sold 25,000 shares at $66.81 ($1.7M)
Taylor Ian, Chief Scientific Officer
Sold 24.1% of holdings ($6.9M position)78,645 shares left2.5x usual sizeFiling
- 2 Form 4 sale ARVNPlan not statedAug 16, 2021 +133 days
Sold 20,000 shares at $87.30 ($1.7M)
Taylor Ian, Chief Scientific Officer
Sold 20.3% of holdings ($8.6M position)78,645 shares left2x usual sizeFiling
- 3 Form 4 sale ARVNPlan not statedNov 15, 2021 +91 days
Sold 20,000 shares at $84.04 ($1.7M)
Taylor Ian, Chief Scientific Officer
Sold 20.3% of holdings ($8.3M position)78,645 shares left1.9x usual sizeFiling
- 4 Form 4 sale ARVNPlan not statedFeb 15, 2022 +92 days
Sold 20,000 shares at $73.02 ($1.5M)
Taylor Ian, Chief Scientific Officer
Sold 20.3% of holdings ($7.2M position)78,645 shares left1x usual sizeFiling
- 5 Form 4 sale ARVNPlan not statedMar 4, 2022 +17 days
Sold 869 shares at $63.94 ($56k)
Taylor Ian, Chief Scientific Officer
Sold 1% of holdings ($5.4M position)83,962 shares left0x usual sizeFiling
- 6 Form 4 sale ARVNPlan not statedMar 1, 2023 +362 days
Sold 1,051 shares at $29.53 ($31k)
Taylor Ian, Chief Scientific Officer
Sold 1% of holdings ($3M position)101,721 shares left0.1x usual sizeFiling
- 7 Form 4 sale ARVNNo planFeb 23, 2024 +359 days
Sold 1,701 shares at $47.05 ($80k)
Taylor Ian, Chief Scientific Officer
No 10b5-1 planSold 1.1% of holdings ($7M position)147,522 shares leftFiling
- 8 Form 4 sale ARVNNo planFeb 24, 2025 +367 days
Sold 9,020 shares at $16.71 ($151k)
Taylor Ian, President, R&D
No 10b5-1 planSold 5.4% of holdings ($2.8M position)159,121 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | Feb 25, 2025 | ARVN | President, R&D | Form 4 sale | 9,020 | $151k | 5.4% | No plan | SEC |
| Feb 23, 2024 | Feb 27, 2024 | ARVN | Chief Scientific Officer | Form 4 sale | 1,701 | $80k | 1.1% | No plan | SEC |
| Mar 1, 2023 | Mar 3, 2023 | ARVN | Chief Scientific Officer | Form 4 sale | 1,051 | $31k | 1.0% | Plan not stated | SEC |
| Mar 4, 2022 | Mar 4, 2022 | ARVN | Chief Scientific Officer | Form 4 sale | 869 | $56k | 1.0% | Plan not stated | SEC |
| Feb 15, 2022 | Feb 17, 2022 | ARVN | Chief Scientific Officer | Form 4 sale | 20,000 | $1.5M | 20.3% | Plan not stated | SEC |
| Nov 15, 2021 | Nov 17, 2021 | ARVN | Chief Scientific Officer | Form 4 sale | 20,000 | $1.7M | 20.3% | Plan not stated | SEC |
| Aug 16, 2021 | Aug 18, 2021 | ARVN | Chief Scientific Officer | Form 4 sale | 20,000 | $1.7M | 20.3% | Plan not stated | SEC |
| Apr 5, 2021 | Apr 7, 2021 | ARVN | Chief Scientific Officer | Form 4 sale | 25,000 | $1.7M | 24.1% | Plan not stated | SEC |
| Mar 2, 2021 | Mar 2, 2021 | ARVN | Chief Scientific Officer | Form 4 sale | 894 | $69k | 1.1% | Plan not stated | SEC |
| Mar 19, 2020 | Mar 23, 2020 | ARVN | Chief Scientific Officer | Form 4 sale | 826 | $31k | 1.2% | Plan not stated | SEC |
| Nov 13, 2019 | Nov 15, 2019 | ARVN | Chief Scientific Officer | Form 4 sale | 10,000 | $280k | 15.3% | Plan not stated | SEC |
| Nov 5, 2019 | Nov 7, 2019 | ARVN | Chief Scientific Officer | Form 4 sale | 10,000 | $236k | 13.2% | Plan not stated | SEC |
| Sep 30, 2019 | Oct 2, 2019 | ARVN | Chief Scientific Officer | Form 4 sale | 10,000 | $219k | 11.7% | Plan not stated | SEC |